| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| OPTIMA MEDICAL INNOVATIONS Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,556 | -1,00 % | Aurora Cannabis Inc.: Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure | NASDAQ | TSX: ACB
Aurora has filed an application with the Alberta Securities Commission for an order requiring Curaleaf to comply with securities laws.
Aurora intends to demonstrate... ► Artikel lesen | |
| CANOPY GROWTH | 0,820 | +0,61 % | Canopy Growth Corporation: Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany | Mr. Blöte's appointment strengthens Canopy Growth's commercial leadership as it drives growth across its European medical cannabis businessCanopy Growth Corporation ("Canopy Growth", "our", "we" or... ► Artikel lesen | |
| TILRAY BRANDS | 3,555 | -2,07 % | Tilray Brands, Inc.: BrewDog Builds Momentum for Next Growth Chapter with Expanded Senior Leadership Team | New appointments strengthen marketing, hospitality, category, and international commercial leadership as BrewDog advances long-term growth under Tilray BrandsELLON, Scotland and LONDON, Sept. 28, 2026... ► Artikel lesen | |
| ABBOTT LABORATORIES | 88,80 | -0,09 % | Gilead vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward? | ||
| SINOPHARM | 1,677 | 0,00 % | SINOPHARM (01099): INTERIM REPORT 2026 | ||
| AMARIN | 11,400 | -1,72 % | Amarin Corporation plc: Amarin Reports 2026 Second Quarter Financial Results Demonstrating Early Success of Fully Partnered International Commercial Strategy and Continued Leading U.S. Market Presence | Q2 2026 Results Highlight Global Volume Growth, Lower Operating Expenses and Positive Cash Flow For Full Year 2026, Company Expects Continued Growth in International Markets, Maintenance of VASCEPA's... ► Artikel lesen | |
| ACADIA PHARMACEUTICALS | 18,040 | -0,55 % | H.C. Wainwright senkt Kursziel für Acadia Pharmaceuticals auf 33 US-Dollar | ||
| BRIDGEBIO PHARMA | 57,71 | +0,31 % | BridgeBio auf dem Bernstein Healthcare Forum: Wachstumskurs mit vier Schlüsselprodukten | ||
| AURINIA PHARMACEUTICALS | 14,405 | -0,17 % | Alliance Advisors LLC: Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences | Little Falls, New Jersey--(Newsfile Corp. - May 19, 2026) - Alliance Advisors is pleased to congratulate Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) on the successful completion of its tender offer... ► Artikel lesen | |
| CNBX PHARMACEUTICALS | - | - | CNBX Pharmaceuticals Inc. - 10-Q, Quarterly Report | ||
| ARGENT BIOPHARMA | 0,011 | 0,00 % | ARGENT BIOPHARMA LIMITED: Notification of cessation of securities - RGT | ||
| CENTR BRANDS | 0,001 | -96,67 % | Centr Brands Corp (2): Centr Brands extends maturity dates of debentures | ||
| LABORATORIOS FARMACEUTICOS ROVI | 59,60 | +0,08 % | Dividendenbekanntmachungen (13.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AS COMPANY SA GRS404003006 - 0,1919 EUR BANK OZK US06417N1037 0,48 USD 0,4204 EUR BEACON MINERALS LIMITED AU000000BCN0 0,1 AUD 0... ► Artikel lesen | |
| AVECHO BIOTECHNOLOGY | 0,013 | -100,00 % | AVECHO BIOTECHNOLOGY LIMITED: Avecho to present at the ASX SMIDcaps Conference | ||
| HERON THERAPEUTICS | 0,251 | 0,00 % | Heron Therapeutics, Inc.: U.S. District Court Issues Decision Regarding CINVANTI Patents | CARY, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the U.S. District Court... ► Artikel lesen |